MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pneumonia, Pneumococcal
Clarametyx Biosciences, Inc.*
Organization & Developments: Clarametyx Biosciences
Parents
Clarametyx Biosciences, Inc.*
Children
*Clarametyx Biosciences is combating persistent and recalcitrant infections through a technology platform targeting the biofilm—a protective layer around bacteria—to enable a more effective immune response or antibiotic intervention.
*Its lead candidate, CMTX-101, is a humanized monoclonal antibody in preclinical development for hospital-acquired pneumonia.
*The Company is building a pipeline of immune-enabling therapies and vaccines for life-threatening bacterial infections associated with biofilms.
Jumps
Finance & Acquisition: Clarametyx Biosciences
Key People: Clarametyx Biosciences